Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

1. Pardo, B.
2. Salazar, R.
3. Ciruelos, E.
4. Cortés-Funes, H.
5. García, M.
6. Majem, M.
7. Montes, A.
8. Cuadra, C.
9. Soto-Matos, A.
10. Lebedinsky, C.
11. Alfaro, V.
12. Paz-Ares, L.